Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

NCT: NCT04097145 · RECRUITING

NCT IDNCT04097145
StatusRECRUITING
Start Date2019-12-11
Completion2031-12-31

Brief Summary

To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team

Frequently Asked Questions

What is Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial?

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial is a clinical trial registered under NCT04097145. Current status: RECRUITING.

What is the status of NCT04097145?

The current status of NCT04097145 (Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial) is: RECRUITING.

When did Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial start?

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial started on 2019-12-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑